These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19663733)

  • 1. Treatment of performance status 2 patients with advanced non-small-cell lung cancer: what we know and what we don't know.
    Tartarone A; Aieta M
    Future Oncol; 2009 Aug; 5(6):837-41. PubMed ID: 19663733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of non-small cell lung cancer patients with performance status2 (PS2).
    Boukovinas I; Kosmidis P
    Lung Cancer; 2009 Jan; 63(1):10-5. PubMed ID: 18586349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of PS2 patients with advanced non-small cell lung cancer.
    Cheong KA; Chrystal K; Harper PG
    Int J Clin Pract; 2006 Nov; 60(11):1493-6. PubMed ID: 16911572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in pretreatment quality of life in a prospective lung cancer trial.
    Siddiqui F; Kohl R; Swann S; Watkins-Bruner D; Movsas B
    J Support Oncol; 2008 Jan; 6(1):33-9. PubMed ID: 18257399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
    Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
    Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of advanced non-small-cell lung cancer in patients with a performance status of 2.
    Lilenbaum R
    Clin Lung Cancer; 2004 Jan; 5(4):209-13. PubMed ID: 14967072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
    Dillman RO; Seagren SL; Propert KJ; Guerra J; Eaton WL; Perry MC; Carey RW; Frei EF; Green MR
    N Engl J Med; 1990 Oct; 323(14):940-5. PubMed ID: 2169587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.
    Lilenbaum RC; List M; Desch C
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):52-4. PubMed ID: 10566612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
    Yang YJ; Park JC; Kim HK; Kang JH; Park SY
    Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
    Lilenbaum R; Axelrod R; Thomas S; Dowlati A; Seigel L; Albert D; Witt K; Botkin D
    J Clin Oncol; 2008 Feb; 26(6):863-9. PubMed ID: 18281658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the randomized phase III trials in non-small cell lung cancer in North America.
    Kelly K
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-2-S8-5. PubMed ID: 9207308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for maintenance therapy in advanced non-small cell lung cancer: current status, unanswered questions and future directions.
    Custodio A; de Castro J
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):338-60. PubMed ID: 21908201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to the treatment of lung cancer.
    Splinter TA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-1-S12-5. PubMed ID: 9331110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for the treatment of lung cancer with lymph node involvement].
    Ikeda N; Tsuboi M; Ohira T; Hirano T; Kato H
    Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):404-7. PubMed ID: 15303439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent topics in chemotherapy for elderly patients with lung cancer].
    Okamoto H; Watanabe K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy].
    Watanabe Y
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.